Mycobacterium Citations List: October 2023
Literature Citations
1. Benzene amide ether Scaffold is Active Against Non-replicating and Intracellular Mycobacterium tuberculosis. Ahmed, S., S. Chowdhury, J. Gomez, D.T. Hung, and T. Parish. ACS Infectious Diseases, 2023. 9(10): p. 1981-1992. PMID[37708378]. PMCID[PMC10580325].
[PubMed]. TB_10_2023.
2. Pyrrole-thiazolidinone Hybrids as a New Structural Class of Broad-spectrum Anti-infectives. Ahmed, S., A. Mital, A. Akhir, D. Saxena, M.N. Ahmad, A. Dasgupta, S. Chopra, and R. Jain. European Journal of Medicinal Chemistry, 2023. 260: 115757. PMID[37659197].
[PubMed]. TB_10_2023.
3. Inoculum-dependent Bactericidal Activity of a Mycobacterium tuberculosis MmpL3 Inhibitor. Berube, B., A. Deshpande, A. Bhagwat, and T. Parish. Microbiology, 2023. 169(6): 001345. PMID[37334886]. PMCID[PMC10333795].
[PubMed]. TB_10_2023.
4. Nanocomplex of Nisin with Carbohydrate for the Treatment of Tuberculosis. Bhavsar, J. and P. Shende. International Journal of Polymeric Materials and Polymeric Biomaterials, 2023. ISI[001063723100001].
[WOS]. TB_10_2023.
5. In Vitro Susceptibility Testing of Imipenem-Relebactam and Tedizolid Against 102 Mycobacterium abscessus Isolates. Burke, A., R. Carter, C. Tolson, J. Congdon, C. Duplancic, E. Bursle, S.C. Bell, J.A. Roberts, and R. Thomson. International Journal of Antimicrobial Agents, 2023. 62(4): 106938. PMID[37517624].
[PubMed]. TB_10_2023.
6. Design, Synthesis, Biological Evaluation and Molecular Dynamics of some Novel 3-phenylpyrazolo[1,5-a]pyrimidine-2,7(1H,4H)-dione Based Compounds as Anti-tubercular Agents. Chauhan, M., C. Prajapati, S. Mirza, R. Barot, R. Yadav, M. Barmade, D. Kakadiya, R. Vijayvargia, B. Haobam, A.T. Baidya, R. Kumar, M.R. Yadav, and P. Murumkar. Journal of Biomolecular Structure and Dynamics, 2023: p. 1-19. PMID[37655680].
[PubMed]. TB_10_2023.
7. New Thiophenyl-pyrazolyl-thiazole Hybrids as DHFR Inhibitors: Design, Synthesis, Antimicrobial Evaluation, Molecular Modeling, and Biodistribution Studies. Dawood, D.H., M.M. Sayed, S.T.K. Tohamy, and E.S. Nossier. ACS Omega, 2023. 8(42): p. 39250-39268. PMID[37901585]. PMCID[PMC10600881].
[PubMed]. TB_10_2023.
8. Synthesis of Novel Furan-based Chalcone Derivatives as Anti-tuberculosis Agents: In Vitro, Cytotoxicity Assessment and In Silico. Dhivya, L.S. and K.M. Kumaradoss. Future Medicinal Chemistry, 2023. 15(18): p. 1687-1701. PMID[37732414].
[PubMed]. TB_10_2023.
9. Quinolone Analogues of Benzothiazinone: Synthesis, Antitubercular Structure-Activity Relationship and ADME Profiling. Dube, P.S., L.J. Legoabe, A. Jordaan, L. Sigauke, D.F. Warner, and R.M. Beteck. European Journal of Medicinal Chemistry, 2023. 258: 115539. PMID[37321107].
[PubMed]. TB_10_2023.
10. Clove Buds Volatile Compounds: Inhibitory Activity on Mycobacterium Growth and Molecular Docking on Mmr Efflux Pump Drug Resistance. El Ghallab, Y., J.J. Eddine, A. Aainouss, M.D. El Messaoudi, M. Dakir, and S. Derfoufi. Chemistry & Biodiversity, 2023. 20(10): e202300895. PMID[37696771].
[PubMed]. TB_10_2023.
11. Fluorescent Nanoassembly of Tetrazole-based Dyes with Amphoteric Surfactants: Investigation of Cyanide Sensing and Antitubercular Activity. Fernandes, R.S., J. Kumari, D. Sriram, and N. Dey. ACS Applied Bio Materials, 2023. 6(10): p. 4158-4167. PMID[37737110].
[PubMed]. TB_10_2023.
12. The In Vitro Effect of New Combinations of Carbapenem-β-Lactamase Inhibitors for Mycobacterium abscessus. Fröberg, G., A. Ahmed, E. Chryssanthou, and L. Davies Forsman. Antimicrobial Agents and Chemotherapy, 2023. 67(10): e0052823. PMID[37671880]. PMCID[PMC10583658].
[PubMed]. TB_10_2023.
13. Chemical Constituents of the Stem of Marsypopetalum modestum and their Bioactivities. Gurgul, A., M.C. Nauman, Z. Wu, G. Shetye, R. Ma, I. Youn, O. Souliya, J. Bisson, J.J. Johnson, and C.T. Che. Natural Product Research, 2023. 37(21): p. 3623-3630. PMID[35819993]. PMCID[PMC9834434].
[PubMed]. TB_10_2023.
14. Polyoxygenated Cyclohexene Derivatives and Other Constituents of Uvaria rufa Stem. Gurgul, A., Z. Wu, K.Y. Han, G. Shetye, K. Sydara, O. Souliya, J.J. Johnson, and C.T. Che. Phytochemistry, 2023. 216: 113884. PMID[37813133].
[PubMed]. TB_10_2023.
15. Synthesis, Characterization, and Antimicrobial Activities of a Starch-based Polymer. Kanth, S., Y. Malgar Puttaiahgowda, and A. Kulal. Carbohydrate Research, 2023. 532: 108900. PMID[37459722].
[PubMed]. TB_10_2023.
16. In Vitro and In Vivo Evaluation of Dual Clofazimine and Verapamil Loaded PLGA Nanoparticles. Kaur, B., M. Kaur, P. Ahlawat, and S. Sharma. Indian Journal of Clinical Biochemistry, 2023. 38(4): p. 466-474. PMID[37746540]. PMCID[PMC10516816].
[PubMed]. TB_10_2023.
17. New Flexible Analogues of 8-Aza-7-deazapurine Nucleosides as Potential Antibacterial Agents. Khandazhinskaya, A., B. Eletskaya, A. Mironov, I. Konstantinova, O. Efremenkova, S. Andreevskaya, T. Smirnova, L. Chernousova, E. Kondrashova, A. Chizhov, K. Seley-Radtke, S. Kochetkov, and E. Matyugina. International Journal of Molecular Sciences, 2023. 24(20): 15421. PMID[37895100]. PMCID[PMC10607158].
[PubMed]. TB_10_2023.
18. Synthesis and Biological Evaluation of 2- (2-Hydroxy-phenylamino)-methylene -cycloheptane-1,3-dione as an Anti-tuberculosis Agent. Lin, L.J., Y.P. Yang, and L.J. Dong. Latin American Journal of Pharmacy, 2023. 42(8): p. 1693-1699. ISI[001066568400021].
[WOS]. TB_10_2023.
19. In Vitro Bioevaluation and Docking Study of Dihydrosphingosine and Ethambutol Analogues Against Sensitive and Multi-drug Resistant Mycobacterium tuberculosis. Linhares, L.A., A. Dos Santos Peixoto, L.A. Correia de Sousa, J.P. Lucena Laet, A.C. da Silva Santos, V.R. Alves Pereira, M.M. Carneiro Neves, L. Ferreira, M.Z. Hernandes, J. de la Vega, A. Pereira-Neves, A. San Feliciano, E.D. Olmo, H.C. Schindler, and L.M.L. Montenegro. European Journal of Medicinal Chemistry, 2023. 258: 115579. PMID[37399709].
[PubMed]. TB_10_2023.
20. Benzylated Sulfamethoxazole Derivatives with Improved Safety Profile as Potential anti-Mycobacterium tuberculosis and Antibacterial Agents. Maepa, J.M. and T.C. Leboho. Journal of Chemistry, 2023. 2023: 4805466. ISI[001070812700002].
[WOS]. TB_10_2023.
21. 5-Substituted Uridines with Activity Against Gram-Positive Bacteria. Makarov, D.A., S.D. Negrya, M.V. Jasko, I.L. Karpenko, P.N. Solyev, V.O. Chekhov, D.N. Kaluzhny, O.V. Efremenkova, B.F. Vasilyeva, A.O. Chizhov, D.A. Avdanina, A.A. Zhgun, S.N. Kochetkov, and L.A. Alexandrova. ChemMedChem, 2023. 8(12): e202300366. ISI[001074457100001].
[WOS]. TB_10_2023.
22. Mercuric-sulphide Based Metallopharmaceutical Formulation as an Alternative Therapeutic to Combat Viral and Multidrug-resistant (MDR) Bacterial Infections. Malarvizhi, K., D. Ramyadevi, B.N. Vedha Hari, H.B. Sarveswari, A.P. Solomon, H. Fang, R.H. Luo, and Y.T. Zheng. Scientific Reports, 2023. 13(1): p. 16706. PMID[37794044]. PMCID[PMC10550948].
[PubMed]. TB_10_2023.
23. Evaluation of Saraca asoca for its Anti-tubercular Potential via Molecular Docking and Molecular Dynamics Simulation Studies. Maurya, S., A. Jain, V. Singh, S. Haque, and B.N. Mishra. ChemistrySelect, 2023. 8(12): e202204899. ISI[001061338500005].
[WOS]. TB_10_2023.
24. Synthesis, Antimicrobial and Antibiofilm Activities, and Molecular Docking Investigations of 2-(1H-Indol-3-yl)-1H-benzo[d]imidazole Derivatives. Mendogralo, E.Y., L.Y. Nesterova, E.R. Nasibullina, R.O. Shcherbakov, D.A. Myasnikov, A.G. Tkachenko, R.Y. Sidorov, and M.G. Uchuskin. Molecules, 2023. 28(20): 7095. PMID[37894573]. PMCID[PMC10609029].
[PubMed]. TB_10_2023.
25. Binding of Piperine to Mycobacterial RNA Polymerase Improves the Efficacy of Rifampicin Activity Against Mycobacterium leprae and Nontuberculous Mycobacteria. Murase, L.S., D.S. Lima, J.V.P. Souza, C.T. Palomo, K.R. Caleffi-Ferracioli, R.B.L. Scodro, V.L.D. Siqueira, F.A.V. Seixas, and R.F. Cardoso. Journal of Biomolecular Structure and Dynamics, 2023. 41(18): p. 8671-8681. PMID[36255291].
[PubMed]. TB_10_2023.
26. Antimycobacterial Precatorin A Flavonoid Displays Antibiofilm Activity Against Mycobacterium bovis BCG. Niño-Padilla, E.I., C. Espitia, C. Velazquez, E. Alday, E. Silva-Campa, A. Burgara-Estrella, J.A. Enciso-Moreno, O. Valenzuela, H. Astiazarán-García, and A. Garibay-Escobar. ACS Omega, 2023. 8(43): p. 40665-40676. PMID[37929145]. PMCID[PMC10621015].
[PubMed]. TB_10_2023.
27. Synthesis, Characterization, In Vitro Antimycobacterial and Cytotoxicity Evaluation, DFT Calculations, Molecular Docking and ADME Studies of New Isomeric Benzimidazole-1,2,3-triazole-quinoline Hybrid Mixtures. Nyoni, N.T.P., N.B. Ncube, M.X. Kubheka, N.P. Mkhwanazi, S. Senzani, T. Singh, and M. Tukulula. Bioorganic Chemistry, 2023. 141: 106904. PMID[37832224].
[PubMed]. TB_10_2023.
28. Novel Quinoline-Based Thiosemicarbazide Derivatives: Synthesis, DFT Calculations, and Investigation of Antitubercular, Antibacterial, and Antifungal Activities. Özcan, E., S.K. Vagolu, M.G. Gündüz, M. Stevanovic, Z. Kökbudak, T. Tønjum, J. Nikodinovic-Runic, Y. Çetinkaya, and D. Doğan Ş. Acs Omega, 2023. 8(43): p. 40140-40152. PMID[37929089]. PMCID[PMC10620885].
[PubMed]. TB_10_2023.
29. Isoxazole Carboxylic acid Methyl ester-based Urea and Thiourea Derivatives as Promising Antitubercular Agents. Sahoo, S.K., O. Ommi, S. Maddipatla, P. Singh, M.N. Ahmad, G. Kaul, S. Nanduri, A. Dasgupta, S. Chopra, and V.M. Yaddanapudi. Molecular Diversity, 2023. 27(5): p. 2037-2052. PMID[36282413]. PMCID[PMC9592870].
[PubMed]. TB_10_2023.
30. SK-03-92 Drug Kills Intracellular Mycobacterium tuberculosis. Schwan, W.R. Antibiotics, 2023. 12(9): 1385. PMID[37760682]. PMCID[PMC10525840].
[PubMed]. TB_10_2023.
31. In Vitro Activity of Rifabutin and Clofazimine to Macrolide-resistant Mycobacterium abscessus Complex Clinical Isolates. Sürücüoğlu, S., N. Özkütük, H. Gazi, and C. Çavuşoğlu. Mikrobiyoloji Bülteni, 2023. 57(4): p. 639-649. PMID[37885391].
[PubMed]. TB_10_2023.
32. Asiaticoside A for the Modulation of 1-TbAd- a Potential Target and Ligand for Extensive Drug Resistance Mycobacterium tuberculosis. Tilwani, K., A. Patel, M. Patel, P. Sojitra, and G. Dave. AMB Express, 2023. 13(1): 111. PMID[37833557]. PMCID[PMC10575824].
[PubMed]. TB_10_2023.
33. Antimycobacterial Activities of Hydroxamic Acids and their Iron(II/III), Nickel(II), Copper(II) and Zinc(II) Complexes. Yang, D., Y. Zhang, I.S. Sow, H. Liang, N. El Manssouri, M. Gelbcke, L. Dong, G. Chen, F. Dufrasne, V. Fontaine, and R. Li. Microorganisms, 2023. 11(10): 2611. PMID[37894269]. PMCID[PMC10609363].
[PubMed]. TB_10_2023.
Patent Citations
34. Anti-tubercular Compositions. Gruber, G., R.W. Bates, and S.P. Ng. Patent. 2023. WO2023-SG50218 2023191725: 51 pp.
[Patent]. TB_10_2023.
35. Pyrrolo[3,2-b]quinoline Compounds as Antibacterial Agents. Haroun, M. and C. Tratrat. Patent. 2023. US2023-125302 11780838: 19 pp.
[Patent]. TB_10_2023.
36. N-(Pyrimido[2,3-b]indol-7-yl)acetamide Compounds as Antibacterial Agents. Haroun, M. and C. Tratrat. Patent. 2023. US2023-157061 11773093: 14 pp.
[Patent]. TB_10_2023.
37. Pyrido[3,4-b]indol-1-one Compounds as Antibacterial Agents. Haroun, M. and C. Tratrat. Patent. 2023. US2023-126765 11773092: 17 pp.
[Patent]. TB_10_2023.
38. 4-Arylamino-2-(6-indolylamino)pyrimidine Compounds as Antibacterial Agents. Haroun, M. and C. Tratrat. Patent. 2023. US2023-134695 11773084: 13 pp.
[Patent]. TB_10_2023.